Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock (Q24187111)

8

0 references

Susanne Unverzagt

1

0 references

Roland Prondzinsky

10

0 references

author name string

Michael Buerke

2

0 references

Antoinette de Waha

3

0 references

Diana Pietzner

5

0 references

Melchior Seyfarth

6

0 references

Holger Thiele

7

0 references

Uwe Zeymer

Cochrane Database of Systematic Reviews

9

0 references

publication date

27 March 2015

0 references

published in

0 references

cites work

Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Initial clinical experience with intraaortic balloon pumping in cardiogenic shock.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

One-Year Survival Following Early Revascularization for Cardiogenic Shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Preoperative intra aortic balloon pumps in patients undergoing coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Aortic counterpulsation: a review of the hemodynamic effects and indications for use.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Mechanical ventilation in conjunction with the intra-aortic balloon pump improves the outcome of patients in profound cardiogenic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

The role of intra-aortic ballon counterpulsation in patients undergoing percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Regional and global left ventricular function during intra-aortic balloon counterpulsation in patients with acute myocardial infarction shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Intraaortic balloon pumping as the postangioplasty strategy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Randomized controlled trial of intraaortic balloon counterpulsation in early myocardial infarction with acute heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction. The Randomized IABP Study Group. Intraaortic Balloon Pump

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Prognosis in cardiogenic shock after acute myocardial infarction in the intervencional era

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis o

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

The balloon pump-assisted coronary intervention study (BCIS-1): rationale and design

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Intra-aortic balloon counterpulsation in patients with acute myocardial infarction without cardiogenic shock. A meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: a comprehensive meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Prognostic value of admission hemoglobin levels in ST-segment elevation myocardial infarction patients presenting with cardiogenic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Should we discontinue intraaortic balloon during cardioplegic arrest? Splanchnic function results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and prognostic implications.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Growing epidemic of coronary heart disease in low- and middle-income countries

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Timing of intra-aortic balloon pump support and 1-year survival

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Impact of intra-aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise th

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

The calm after the storm: long-term survival after cardiogenic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Comparison of hemodynamic effects of enhanced external counterpulsation and intra-aortic balloon pumping in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Age and the utilization of cardiac catheterization following uncomplicated first acute myocardial infarction treated with thrombolytic therapy (The Second National Registry of Myocardial Infarction [NRMI-2])

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Preoperative intraaortic balloon pump enhances cardiac performance and improves the outcome of redo CABG

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Vascular complications of the intraaortic balloon pump in patients undergoing open heart operations: 15-year experience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Mechanical complications of intra-aortic balloon counterpulsation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries f

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Results of a randomized prospective trial of intraaortic balloon counterpulsation and intravenous nitroglycerin in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial In

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Evaluation of preoperative intra-aortic balloon pump support in high risk coronary patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

The role of intra-aortic counterpulsation in high-risk OPCAB surgery: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

The effect of preoperative intra-aortic balloon pump support in patients with coronary artery disease, poor left-ventricular function (LVEF < 40%), and hypertensive LV hypertrophy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Medical therapy of acute myocardial infarction by application of hemodynamic subsets (first of two parts)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Medical therapy of acute myocardial infarction by application of hemodynamic subsets (second of two parts)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Temporal trends in cardiogenic shock complicating acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Intraaortic balloon support for myocardial infarction with cardiogenic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Global sodium consumption and death from cardiovascular causes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Aortic counterpulsation in acute myocardial infarction: Physiologically important but does the patient benefit?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

The role of heparin anticoagulation during intra-aortic balloon counterpulsation in the coronary care unit

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Prophylactic intra-aortic balloon pump reduces C-reactive protein levels and early mortality in high-risk patients undergoing percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Why are we failing to implement effective therapies in cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Mechanical circulatory support in cardiogenic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Intra-aortic balloon counterpulsation as a bridge to heart transplantation does not impair long-term survival.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Intraaortic balloon assistance in intractable cardiogenic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

In which patients should sheathless IABP be used? An analysis of vascular complications in 1211 cases.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Preoperative intra-aortic balloon pump in patients undergoing coronary bypass surgery: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Intra-aortic balloon pump improves clinical prognosis and attenuates C-reactive protein level in acute STEMI complicated by cardiogenic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Trends in intra-aortic balloon counterpulsation: comparison of a 669 record Australian dataset with the multinational Benchmark Counterpulsation Outcomes Registry.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Meta-analyses based on abstracted data: a step in the right direction, but only a first step.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Do all nonsurvivors of cardiogenic shock die with a low cardiac index?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Complications of intra-aortic balloon in a cohort of hospitalized patients: implications for nursing care

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007398.PUB3

7 January 2021

10.1002/14651858.CD007398.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

25812932

1 reference

Consolidated OpenCitations Corpus – April 2017